HK1067985A1 - Lactic acid bacteria and their use for treating and preventing cancer - Google Patents

Lactic acid bacteria and their use for treating and preventing cancer

Info

Publication number
HK1067985A1
HK1067985A1 HK05101525A HK05101525A HK1067985A1 HK 1067985 A1 HK1067985 A1 HK 1067985A1 HK 05101525 A HK05101525 A HK 05101525A HK 05101525 A HK05101525 A HK 05101525A HK 1067985 A1 HK1067985 A1 HK 1067985A1
Authority
HK
Hong Kong
Prior art keywords
lactic acid
acid bacteria
treating
preventing cancer
cancer
Prior art date
Application number
HK05101525A
Other languages
English (en)
Inventor
Fracois-Marie Liquet
Cindy Baldwin
Monique Lacroix
Original Assignee
Bio K Plus International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio K Plus International Inc filed Critical Bio K Plus International Inc
Publication of HK1067985A1 publication Critical patent/HK1067985A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
HK05101525A 2001-11-27 2005-02-23 Lactic acid bacteria and their use for treating and preventing cancer HK1067985A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002364249A CA2364249A1 (fr) 2001-11-27 2001-11-27 Effet de bacteries lactiques sur l'apoptose cellulaire de tumeur
PCT/CA2002/001826 WO2003045405A2 (fr) 2001-11-27 2002-11-27 Bacteries lactiques et leur usage dans le traitement et la prevention du cancer

Publications (1)

Publication Number Publication Date
HK1067985A1 true HK1067985A1 (en) 2005-04-22

Family

ID=4170739

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05101525A HK1067985A1 (en) 2001-11-27 2005-02-23 Lactic acid bacteria and their use for treating and preventing cancer

Country Status (9)

Country Link
US (1) US7887794B2 (de)
EP (1) EP1450832B1 (de)
AT (1) ATE336258T1 (de)
AU (1) AU2002349226A1 (de)
CA (1) CA2364249A1 (de)
DE (1) DE60214029T2 (de)
HK (1) HK1067985A1 (de)
MX (1) MXPA04005002A (de)
WO (1) WO2003045405A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2448843A1 (fr) 2003-11-13 2005-05-13 Bio-K Plus International Inc. Effets de differents surnageants de bacteries lactiques de bio-k plus sur des lignees cellulaires endotheliales
TW200700074A (en) 2005-03-04 2007-01-01 Calpis Co Ltd Inducer of t cell apoptosis
EP2015760A1 (de) * 2006-05-10 2009-01-21 Institut National de la Recherche Agronomique Verwendung von zellen, die ein spezifisches dns-molekül enthalten, als zytopathische mittel zur unterdrückung der zellproliferation
US20080124355A1 (en) 2006-09-22 2008-05-29 David Gordon Bermudes Live bacterial vaccines for viral infection prophylaxis or treatment
GB0624745D0 (en) * 2006-12-11 2007-01-17 Univ Sheffield Acetylation
KR20090092315A (ko) 2006-12-21 2009-08-31 칼피스가부시키가이샤 ＩｇＡ 생산 촉진제
US8241623B1 (en) 2009-02-09 2012-08-14 David Bermudes Protease sensitivity expression system
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
FR2960001A1 (fr) * 2010-05-12 2011-11-18 Univ Rennes Vecteur recombinant pour la production et la secretion de sequences d'acides amines d'interet par les bacteries propioniques et ses applications
US9476056B2 (en) 2010-05-12 2016-10-25 Universite De Rennes 1 Recombinant vector for producing and secreting peptide or protein of interest by propionibacteria and applications thereof
KR20120015644A (ko) * 2010-08-12 2012-02-22 박진형 항암 활성을 갖는 락토바실러스 균주 및 이를 활성성분으로 포함하는 항암 활성 조성물
US9593339B1 (en) 2013-02-14 2017-03-14 David Gordon Bermudes Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN114028432A (zh) * 2021-11-05 2022-02-11 上海市第十人民医院 双歧杆菌提升铂类化疗药物敏感性的药物新用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69737420T2 (de) 1996-11-29 2007-11-15 Bio K + International Inc., Montreal Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung

Also Published As

Publication number Publication date
DE60214029T2 (de) 2007-03-29
MXPA04005002A (es) 2005-09-08
ATE336258T1 (de) 2006-09-15
DE60214029D1 (de) 2006-09-28
WO2003045405A2 (fr) 2003-06-05
US7887794B2 (en) 2011-02-15
EP1450832B1 (de) 2006-08-16
WO2003045405A3 (fr) 2003-10-09
CA2364249A1 (fr) 2003-05-27
US20050208033A1 (en) 2005-09-22
AU2002349226A1 (en) 2003-06-10
EP1450832A2 (de) 2004-09-01

Similar Documents

Publication Publication Date Title
HK1067985A1 (en) Lactic acid bacteria and their use for treating and preventing cancer
MY127895A (en) New lactic acid bacteria strains capable of preventing diarrhoea
IL156490A0 (en) Probiotic compounds derived from lactobacillus casei strain ke01
PL348973A1 (en) Oral administration of lactobacillus for the treatment and prevention of urogenital infection
GB0124580D0 (en) New composition
ITMI20051509A1 (it) Ceppi di bifidobacterium produttori di acido folico loro formulazioni e uso
MX2011012069A (es) Micro-organismos no-replicantes y su efecto inmuno estimulador.
TW200514847A (en) Lactic acid bacteria having mucosal immunopotentiation effect
UA94056C2 (uk) Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій
IL181601A0 (en) Ferulate esterase producing strains and methods of using same
IL160049A0 (en) Probiotic lactobacillus salivarius strains
NZ516020A (en) Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
GB2460781A (en) Probiotic bifidobacterium strains
GB2465051A (en) Probiotic bifidobacterium strains
IL160050A0 (en) Probiotic lactobacillus casei strains
PT1296694E (pt) Probióticos na prevenção primária de doenças atópicas
MX2010013917A (es) Induccion de floculacion en organismos fotosinteticos.
HK1079104A1 (en) Orally administrable composition to human for the photoprotection of the skin
BRPI0511314A (pt) bactérias lácticas e seu uso na prevenção de diarréia
WO2003039260A3 (en) PROBIOTIC COMPOSITIONS
MX2022008666A (es) Composicion probiotica para su uso como antioxidante.
AU1904002A (en) Cytochrome p450 monooxygenases consisting of thermophilic bacteria
Chu et al. Probiotics characterization of Lactobacillus species isolated from Kimchi
Shin et al. Probiotic properties of lactic acid bacteria isolated from feces and kimchi
ITMI20041232A1 (it) Composizione nutraceutica contenente un numero elevato di fermenti lattici utile come sinbiotico

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20121127